8-K
Current Report
NEKTAR THERAPEUTICS Filed Acc 0001181431-08-058261
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading rrd221566.htm…